Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00461162 · ClinicalTrials.gov registry record · Phase 1
Dyspnea Self-Management: Internet or Face-to-Face
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 125
- Enrollment target
NCT00461162 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 125 participants.
The verdict
NCT00461162, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 125 participants
- Enrollment target
Study Summary
Chronic obstructive pulmonary disease, including emphysema and chronic bronchitis, is the fourth most common cause of death and the second leading cause of disability in the United States. COPD is estimated to be responsible for more than 13.4 million physician visits and 13% of hospitalizations nationally. These hospitalizations are usually caused by acute exacerbations characterized by an increase in symptoms including dyspnea or shortness of breath (SOB), cough, wheezing, and sputum production. The significant disability for people with COPD is primarily due to the symptom of dyspnea (shortness of breath) that affects an individual's quality of life more than does the physiological impairment. Despite optimal medical and pharmacological therapy, most people with COPD continue to suffer from chronic and progressive dyspnea and other symptoms of cough and fatigue. We have previously shown that an individualized face-to-face dyspnea self-management program was effective in improving dyspnea with activities of daily living (ADL), physical functioning, and self-efficacy for managing dyspnea. Using an experimental longitudinal design, the i-DSMP will be compared to the Face-to-Face Dyspnea Self-Management Program (f-DSMP) and to an Attention Control (AC) intervention
Interventions
- BEHAVIORAL Attention Control
- BEHAVIORAL Internet DSMP
- BEHAVIORAL Face-to-Face Dyspnea Self-management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2007-01 |
| Est. Completion | 2011-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00461162
The ClinicalTrials.gov registry entry for NCT00461162 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Attention Control is the first listed.
NCT00461162 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00461162 about?
NCT00461162 is a clinical study titled "Dyspnea Self-Management: Internet or Face-to-Face". Chronic obstructive pulmonary disease, including emphysema and chronic bronchitis, is the fourth most common cause of death and the second leading cause of disability in the United States. COPD is estimated to be responsible for more than 13.4 million physician visits and 13% of hospitalizations nat...
What is the current status of trial NCT00461162?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 125 participants. The study started on 2007-01. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00461162?
The interventions under investigation include: Attention Control (BEHAVIORAL), Internet DSMP (BEHAVIORAL), Face-to-Face Dyspnea Self-management (BEHAVIORAL).
Who is sponsoring clinical trial NCT00461162?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.